scispace - formally typeset
P

Paula M. Pitha

Researcher at Johns Hopkins University

Publications -  212
Citations -  18879

Paula M. Pitha is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Interferon & Gene. The author has an hindex of 70, co-authored 212 publications receiving 18298 citations. Previous affiliations of Paula M. Pitha include Salk Institute for Biological Studies & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

TL;DR: These studies suggest that TRIF and TRAM both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during the innate immune response to LPS.
Journal ArticleDOI

Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation

TL;DR: Interestingly, virus infection resulted in the association of IRF-3 with the CREB binding protein (CBP) coactivator, as detected by coimmunoprecipitation with anti-CBP antibody, an interaction mediated by the C-terminal domains of both proteins.
Journal Article

E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas

TL;DR: The data demonstrate that frequent loss of E-cad expression in human breast and prostate carcinomas results from hypermethylation of the E- cad promoter region.
Journal ArticleDOI

Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7

TL;DR: Evidence is presented that guanosine analogs activate immune cells via TLR7 by a pathway that requires endosomal maturation, and the B cell-stimulating and antiviral activities of the guanosin analogs may be explained by theirTLR7-activating capacity.
Journal ArticleDOI

The growing family of interferon regulatory factors

TL;DR: Understanding the molecular mechanisms by which the IRFs affect these important cellular events and IFN expression will contribute to a greater understanding of events leading to various viral, immune and malignant disease states and will suggest novel strategies for antiviral and immune modulatory therapy.